395
Views
10
CrossRef citations to date
0
Altmetric
Original Articles

Cannabis for Cognitive Enhancement as a New Coping Strategy? Results From a Survey of Students at Four Universities in Germany

, , , &

References

  • Babcock, Q., & Byrne, T. (2000). Student perceptions of methylphenidate abuse at a public liberal arts college. The Journal of American College Health, 49, 143–145.
  • Bagot, K. S., & Kaminer, Y. (2014). Efficacy of stimulants for cognitive enhancement in non-attention deficit hyperactivity disorder youth: A systematic review. Addiction, 109, 547–557.
  • de Jongh, R., Bolt, I., Schermer, M., & Olivier, B. (2008). Botox for the brain: Enhancement of cognition, mood and pro-social behavior and blunting of unwanted memories. Neuroscience and Biobehavioural Reviews, 32, 760–776.
  • Deasy, C., Coughlan, B., Pironom, J., Jourdan, D., & Mcnamara, P. M. (2015). Psychological distress and lifestyle of students: Implications for health promotion. Health Promotion International, 30, 77–87.
  • Degenhardt, L., & Hall, W. (2012). Extent of illicit drug use and dependence, and their contribution to the global burden of disease. The Lancet, 379, 55–70.
  • Deline, S., Baggio, S., Studer, J., N'Goran, A. A., Dupuis, M., Henchoz, Y., … Gmel, G. (2014). Use of neuroenhancement drugs: Prevalence, frequency and use expectations in Switzerland. International Journal of Environmental Research and Public Health, 11, 3032–3045.
  • Dietz, P., Striegel, H., Franke, A. G., Lieb, K., Simon, P., & Ulrich, R. (2013). Randomized response estimates for the 12-month prevalence of cognitive-enhancing drug use in university students. Pharmacotherapy, 33, 44–50.
  • Forlini, C., Schildmann, J., Beranek, R., Roser, P., & Vollmann, J. (2015). Knowledge, experiences and views of German university students toward neuroenhancement: An empirical-ethical analysis. Neuroethics, 8, 83–92. doi:10.1007/s12152-014-9218-z
  • Franke, A. G., Bonertz, C., Christmann, M., Huss, M., Fellgiebel, A., Hildt, E., & Lieb, K. (2011). Non-medical use of prescription stimulants and illicit use of stimulants for cognitive enhancement in pupils and students in Germany. Pharmacopsychiatry, 44, 60–66.
  • Franke, A. G., Christmann, M., Bonertz, C., Fellgiebel, A., Huss, M., & Lieb, K. (2011). Use of coffee, caffeinated drinks and caffeine tablets for cognitive enhancement in pupils and students in Germany. Pharmacopsychiatry, 44, 331–338.
  • Franke, A. G., Hildt, E., & Lieb, k. (2011). Patterns of misuse of stimulants for pharmacological neuroenhancement in students. Suchttherapie, 12, 167–173.
  • Franke, A. G., & Lieb, K. (2010). Pharmacological neuroenhancement and brain doping: Chances and risks. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz, 53, 853–859.
  • Franke, A. G., Lieb, K., & Hildt, E. (2012). What users think about the differences between caffeine and illicit/prescription stimulants for cognitive enhancement. PLoS One, 7, e40047.
  • Franke, A. G., Schwarze, C. E., Christmann, M., Bonertz, C., Hildt, E., & Lieb, K. (2012). Characteristics of university students using stimulants for cognitive enhancement: A pilot study. Psychiatrische Praxis, 39, 174–180.
  • Green, B., Kavanagh, D. J., & Young, R. M. (2004). Reasons for cannabis use in men with and without psychosis. Drug and Alcohol Review, 23, 445–453.
  • Johns, A. (2001). Psychiatric effects of cannabis. British Journal of Psychiatry, 178, 116–122.
  • Kudlow, P. A., Naylor, K. T., Xie, B., & McIntyre, R. S. (2013). Cognitive enhancement in Canadian medical students. Journal of Psychoactive Drugs, 45, 360–365.
  • Kuepper, R., van Os, J., Lieb, R., Wittchen, H. U., Hofler, M., & Henquet, C. (2011). Continued cannabis use and risk of incidence and persistence of psychotic symptoms: 10 year follow-up cohort study. British Medical Journal, 342, d738.
  • Lee, C. M., Neighbors, C., & Woods, B. A. (2007). Marijuana motives: Young adults' reasons for using marijuana. Addictive Behaviour, 32, 1384–1394.
  • Lucke, J. C., Bell, S. K., Partridge, B. J., & Hall, W. D. (2011). Academic doping or Viagra for the brain? The history of recreational drug use and pharmacological enhancement can provide insight into these uses of neuropharmaceuticals. EMBO Reports, 12, 197–201.
  • Lundqvist, T. (2005). Cognitive consequences of cannabis use: Comparison with abuse of stimulants and heroin with regard to attention, memory and executive functions. Pharmacology Biochemistry and Behaviour Journal, 81, 319–330.
  • Partridge, B. J., Bell, S. K., Lucke, J. C., Yeates, S., & Hall, W. D. (2011). Smart drugs “as common as coffee”: Media hype about neuroenhancement. PLoS One, 6, e28416.
  • Repantis, D., Schlattmann, P., Laisney, O., & Heuser, I. (2010). Modafinil and methylphenidate for neuroenhancement in healthy individuals: A systematic review. Pharmacological Research, 62, 187–206.
  • Simons, J., Correia, C. J., & Carey, K. B. (2000). Comparison of motives for Marihuana and alcohol use among experienced users. Addictive Behaviour, 25, 153–160.
  • Sinha, R. (2008). Chronic stress, drug use, and vulnerability to addiction. Annals of the New York Academy of Sciences, 1141, 105–130.
  • Teter, C. J., McCabe, S. E., Cranford, J. A., Boyd, C. J., & Guthrie, S. K. (2005). Prevalence and motives for illicit use of prescription stimulants in an undergraduate student sample. The Journal of American College Health, 53, 253–262.
  • Webb, J. R., Valasek, M. A., & North, C. S. (2013). Prevalence of stimulant use in a sample of US medical students. Annals of Clinical Psychiatry, 25, 27–32.
  • Wilens, T. E., Adler, L. A., Adams, J., Sgambati, S., Rotrosen, J., Sawtelle, R., … Fusillo, S. (2008). Misuse and diversion of stimulants prescribed for ADHD: A systematic review of the literature. Journal of the American Academy of Child and Adolescent Psychiatry, 47, 21–31.
  • Wittchen, H. U., Frohlich, C., Behrendt, S., Gunther, A., Rehm, J., Zimmermann, P., … Perkonigg, A. (2007). Cannabis use and cannabis use disorders and their relationship to mental disorders: A 10-year prospective-longitudinal community study in adolescents. Drug and Alcohol Dependence, 88(Suppl. 1), S60–S70.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.